RECRUITING

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to look at the amount of function that returns in participants that have reconstruction with bone graft or artificial device and in participants who have tumor surgery plus regenerative osseous surgery. The study will look at the level of function for a period of 3 years after the surgery. Another purpose of this study is to look at how well the bone heals in participants undergoing regenerative surgery

Official Title

Assessment of Healing and Function After Surgical Reconstruction for Neoplasms Involving Bone

Quick Facts

Study Start:2018-02-14
Study Completion:2025-02-14
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03442465

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All patients undergoing reconstructive surgery for neoplasms involving bone on the orthopaedic surgery service at MSK
  2. * Current or prior history of primary neoplasms involving osseous structures, including all subtypes
  3. * Confirmation of diagnosis that has been performed by the MSK's Department of Pathology via direct review of tissue/slides
  4. * Patients must read and understand English
  5. * Age \>/=4
  6. * Patients must read and understand English
  1. * Patients that weight \<17 kilograms

Contacts and Locations

Study Contact

Daniel Prince, MD, MPH
CONTACT
212-639-6488
princed@mskcc.org
John Healey, MD
CONTACT
212-639-7610
healeyj@mskcc.org

Principal Investigator

Daniel Prince, MD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Monmouth (Consent and Followup)
Middletown, New Jersey, 07748
United States
Memorial Sloan Kettering Westchester (Consent and Followup)
Harrison, New York, 10604
United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10021
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Daniel Prince, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-02-14
Study Completion Date2025-02-14

Study Record Updates

Study Start Date2018-02-14
Study Completion Date2025-02-14

Terms related to this study

Keywords Provided by Researchers

  • 18-014
  • Memorial Sloan Kettering Cancer Center

Additional Relevant MeSH Terms

  • Bone Sarcoma
  • Osteosarcoma
  • Chondrosarcoma
  • Ewing's Sarcoma
  • Osseous Sarcoma
  • Bone Neoplasm